- Home
- SAVA vs WT Comparison
SAVA vs WT Comparison
Compare SAVA & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- WT
- Stock Information
- Founded
- SAVA 1998
- WT 1985
- Country
- SAVA United States
- WT United States
- Employees
- SAVA N/A
- WT N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- WT Investment Bankers/Brokers/Service
- Sector
- SAVA Health Care
- WT Finance
- Exchange
- SAVA Nasdaq
- WT Nasdaq
- Market Cap
- SAVA 1.3B
- WT 1.5B
- IPO Year
- SAVA N/A
- WT N/A
- Fundamental
- Price
- SAVA $27.08
- WT $9.89
- Analyst Decision
- SAVA Buy
- WT Buy
- Analyst Count
- SAVA 3
- WT 8
- Target Price
- SAVA $107.00
- WT $11.84
- AVG Volume (30 Days)
- SAVA 1.9M
- WT 1.2M
- Earning Date
- SAVA 11-05-2024
- WT 10-25-2024
- Dividend Yield
- SAVA N/A
- WT 1.22%
- EPS Growth
- SAVA N/A
- WT N/A
- EPS
- SAVA N/A
- WT 0.49
- Revenue
- SAVA N/A
- WT $385,139,000.00
- Revenue This Year
- SAVA N/A
- WT $25.27
- Revenue Next Year
- SAVA N/A
- WT $8.49
- P/E Ratio
- SAVA N/A
- WT $20.23
- Revenue Growth
- SAVA N/A
- WT 22.85
- 52 Week Low
- SAVA $8.79
- WT $6.06
- 52 Week High
- SAVA $42.20
- WT $12.02
- Technical
- Relative Strength Index (RSI)
- SAVA 46.80
- WT 49.01
- Support Level
- SAVA $26.10
- WT $9.62
- Resistance Level
- SAVA $31.65
- WT $10.03
- Average True Range (ATR)
- SAVA 2.55
- WT 0.21
- MACD
- SAVA -0.50
- WT -0.00
- Stochastic Oscillator
- SAVA 15.08
- WT 33.97
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models, and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime.